Treatment Outcomes and Toxicities for Patients with Hepatocellular Carcinoma Treated with Atezolizumab and Bevacizumab

被引：0
|
作者：
Pakeerathan, Veenaa [1 ]
Babu, Hari [1 ]
Andelkovic, Vladimir [1 ]
机构：
[1] Princess Alexandra Hosp, Woolloongabba, Qld, Australia
来源：
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：54 / 55
页数：2
相关论文
共 50 条
  • [1] Predicting Outcomes of Atezolizumab and Bevacizumab Treatment in Patients with Hepatocellular Carcinoma
    Han, Ji Won
    Jang, Jeong Won
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (14)
  • [2] Toxicities and Outcomes of Radiation Therapy with Atezolizumab Plus Bevacizumab for Hepatocellular Carcinoma
    Ludmir, Ethan
    Manzar, Gohar
    De, Brian
    Abana, Chike
    Lee, Sunyoung
    Javle, Milind
    Kaseb, Ahmed
    Vauthey, Jean-Nicolas
    Cao, Hop Tran
    Koong, Albert
    Smith, Grace
    Taniguchi, Cullen
    Holliday, Emma
    Das, Prajnan
    Koay, Eugene
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2022, 45 (09): : S1 - S2
  • [3] Outcomes and safety of DAA treatment in HCV cirrhotic patients treated with Atezolizumab- Bevacizumab for hepatocellular carcinoma
    Stella, L.
    Cabibbo, G.
    Iavarone, M.
    Piscaglia, F.
    Tovoli, F.
    Marra, F.
    Mazzarelli, C.
    Tortora, R.
    Aghemo, A.
    De Nicola, S.
    Bhoori, S.
    Pallozzi, M.
    Gasbarrini, A.
    Cerrito, L.
    Ponziani, F. R.
    DIGESTIVE AND LIVER DISEASE, 2025, 57
  • [4] Clinical Outcomes With Lenvatinib in Patients Previously Treated With Atezolizumab/Bevacizumab for Advanced Hepatocellular Carcinoma
    Muto, Hisanori
    Kuzuya, Teiji
    Kawabe, Naoto
    Ohno, Eizaburo
    Funasaka, Kohei
    Nagasaka, Mitsuo
    Nakagawa, Yoshihito
    Miyahara, Ryoji
    Shibata, Tomoyuki
    Hashimoto, Senju
    Katano, Yoshiaki
    Hirooka, Yoshiki
    ANTICANCER RESEARCH, 2023, 43 (10) : 4673 - 4682
  • [5] Sarcopenia predicts outcomes in patients with hepatocellular carcinoma treated with atezolizumab and bevacizumab: A multicenter cohort study
    Nam, H.
    Kim, Y.
    Park, H.
    ANNALS OF ONCOLOGY, 2023, 34 : S128 - S128
  • [6] Management of portal hypertension in patients treated with atezolizumab and bevacizumab for hepatocellular carcinoma
    Ollivier-Hourmand, Isabelle
    Allaire, Manon
    Cervoni, Jean Paul
    JOURNAL OF HEPATOLOGY, 2022, 77 (02)
  • [7] Validation of the CRAFITY score in patients with hepatocellular carcinoma treated with atezolizumab and bevacizumab
    Scheiner, Bernhard
    Sartoris, Riccardo
    D'Alessio, Antonio
    Fulgenzi, Claudia
    Pomej, Katharina
    Balcar, Lorenz
    Bouattour, Mohamed
    Sidali, Sabrina
    Himmelsbach, Vera
    Finkelmeier, Fabian
    Schulze, Kornelius
    von Felden, Johann
    Hucke, Florian
    Shmanko, Kateryna
    Siebenhuner, Alexander
    Mertens, Joachim C.
    De Dosso, Sara
    Ebert, Matthias
    Teufel, Andreas
    Waldschmidt, Dirk-Thomas
    Radu, Iuliana Pompilia
    Krall, Anja
    Trauner, Michael
    Dufour, Jean-Francois
    Wege, Henning
    Weinmann, Arndt
    Trojan, Joerg
    Stauber, Rudolf E.
    Peck-Radosavljevic, Markus
    Hsu, Wei-Fan
    Vogel, Arndt
    Ronot, Maxime
    Pinato, David J.
    Pinter, Matthias
    JOURNAL OF HEPATOLOGY, 2023, 78 : S491 - S492
  • [8] Hepatocellular carcinoma with gastric adenocarcinoma treated with atezolizumab and bevacizumab
    Suga, Takayoshi
    Kimura, Yuko
    Furuya, Kensuke
    Sato, Hiroko
    CLINICAL CASE REPORTS, 2023, 11 (09):
  • [9] Considering nutritional status to improve outcomes of patients treated by atezolizumab-bevacizumab for advanced hepatocellular carcinoma
    Allaire, Manon
    Avila, Matias A.
    LIVER INTERNATIONAL, 2024, 44 (06) : 1276 - 1277
  • [10] Alterations of Nutrient Elements in Hepatocellular Carcinoma Patients Treated with Atezolizumab-Bevacizumab
    Xiao, Shuyue
    Huang, Xiaohui
    Liu, Shuer
    Jin, Di
    Liu, Zheng
    NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2025, 77 (02): : 244 - 251
12345